Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Asset Utilization Ratio (2017 - 2024)

Lite Strategy (LITS) posted Asset Utilization Ratio of 1.16 for Q2 2024, up 30.09% on a QoQ basis from 0.89 in Q1 2024, and up 202.82% year-over-year from 0.38 in Q3 2023.

Analysis

Lite Strategy (LITS) Asset Utilization Ratio (2017 - 2024) Analysis & Trends

Lite Strategy has reported Asset Utilization Ratio for 8 years, with the latest figure at 1.16 in Q2 2024.

  • On a quarterly basis, Asset Utilization Ratio rose 202.82% year-over-year to 1.16 in Q2 2024; TTM through Jun 2024 was 1.16, a 202.82% increase from a year earlier, with the FY2024 full-year figure at 0.81, up 146.31% from the prior year.
  • Asset Utilization Ratio was 1.16 for Q2 2024 at Lite Strategy, up from 0.89 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 1.16 in Q2 2024, with the low at 0.04 in Q1 2020.
  • Average Asset Utilization Ratio over 5 years is 0.4, with a median of 0.23 recorded in 2020.
  • The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio surged 508.32% in 2021, then sank 32.87% in 2022.
  • Over 5 years, Asset Utilization Ratio stood at 0.22 in 2020, then retreated by 17.2% to 0.18 in 2021, then jumped by 120.7% to 0.4 in 2022, then soared by 100.95% to 0.81 in 2023, then jumped by 43.47% to 1.16 in 2024.
  • The last three Asset Utilization Ratio figures came in at 1.16 (Q2 2024), 0.89 (Q1 2024), and 0.81 (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 0.40
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 0.47
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 0.38
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 0.20
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 0.90
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.33
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 0.00
10 Lite Strategy 38.03 Mn 30.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 1.16
Mar 31, 2024 0.89
Dec 31, 2023 0.81
Sep 30, 2023 0.95
Jun 30, 2023 0.38
Mar 31, 2023 0.42
Dec 31, 2022 0.40
Sep 30, 2022 0.24
Jun 30, 2022 0.22
Mar 31, 2022 0.18
Dec 31, 2021 0.18
Sep 30, 2021 0.20
Jun 30, 2021 0.19
Mar 31, 2021 0.27
Dec 31, 2020 0.22
Sep 30, 2020 0.16
Jun 30, 2020 0.19
Mar 31, 2020 0.04
Dec 31, 2019 0.05
Sep 30, 2019 0.07